secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clearside Biomedical, Inc. (CLSDQ)
CIK:        0001539029
Form:       8-K
Filed at:   2025-09-11T23:59:59+00:00
Accession:  0001193125-25-200747
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clearside Biomedical files 1-for-15 reverse stock split, reduces authorized shares to 26.7M
--------------------------------------------------------------------------------

- Reverse stock split effective September 12, 2025 at 5:00 p.m. ET; split-adjusted trading begins September 15, 2025.
- Every 15 outstanding shares combine into 1; no fractional shares issued – cash in lieu.
- Authorized common stock reduced from 400M to 26,666,666; par value unchanged at $0.001.
- Proportionate adjustments to stock options, RSUs, warrants, and equity plan reserves.
- New CUSIP 185063203; Nasdaq ticker CLSD unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1539029/000119312525200747/0001193125-25-200747-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1539029/000119312525200747/clsd-20250910.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-200747

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer